受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | KX 01 | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
化学式 | C26H29N3O3 |
|||
分子量 | 431.53 | CAS No. | 897016-82-9 | |
Solubility (25°C)* | 体外 | DMSO | 86 mg/mL (199.29 mM) | |
Water | Insoluble | |||
Ethanol | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | Tirbanibulin, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2. |
---|---|
in vitro | KX2-391 is a Src inhibitor that is directed to the Src substrate pocket. KX2-391 shows steep dose-response curves against Huh7 (GI 50 = 9 nM), PLC/PRF/5 (GI 50 = 13 nM), Hep3B (GI 50 = 26 nM), and HepG2 (GI 50 = 60 nM), four hepatic cell cancer (HCC) cell lines. [1] KX2-391 is found to inhibit certain leukemia cells that are resistant to current commercially available drugs, such as those derived from chronic leukemia cells with the T3151 mutation. KX2-391 is evaluated in engineered Src driven cell growth assays inNIH3T3/c-Src527F and SYF/c-Src527F cells and exhibits GI50 with 23 nM and 39 nM, respectively. [2] |
in vivo | In pre-clinical animal models of cancer, orally administered KX2-391 is shown to inhibit primary tumor growth and to suppress metastasis. [2] |
細胞アッセイ | 細胞株 | Huh7, PLC/PRF/5, Hep3B, and HepG2 cell lines |
---|---|---|
濃度 | 6,564 to 0.012 nM | |
反応時間 | 3 days | |
実験の流れ | Liver cell lines including Huh7, PLC/PRF/5, Hep3B, and HepG2 (NutriCyte, Buffalo, NY) are routinely cultured and maintained in basal medium containing 2% fetal bovine serum (FBS) at 37 °C and 5% CO2. Cells are seeded at 4.0 × 103/190 μL and 8.0 × 103/190 μL per well of 96-well plate in basal medium containing 1.5% FBS. These are cultured overnight at 37 °C and 5% CO2 prior to the addition of KX2-391, at concentrations ranging from 6,564 to 0.012 nM in triplicates. Treated cells are incubated for 3 days. Ten microliters of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (5 mg/mL) is then added to each well on day 3 and cells incubated for 4 hours. The formazan product is dissolved with 10% SDS in dilute HCl. Optical density at 570 nm is measured by using BioTek Synergy HT multiplatform microplate reader. For comparison of activity and potency, parallel experiments are performed using KX2-391. Growth inhibition curves, 50% inhibition concentration (GI50), and 80% inhibition concentration (GI80) are determined using GraphPad Prism 5 statistical software. Data are normalized to represent percentage of maximum response as well as reported in optical density at wavelength of 570 nm (OD570) signal format. |
|
, , Neurotox Res, 2015, 27(4):384-98.
Data from [Data independently produced by , , Front Immunol, 2018, 9:2433]
Data from [Data independently produced by , , Oncotarget, 2016, 7(31):50027-50042]
Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation [ Adv Sci (Weinh), 2023, 10(7):e2202956] | PubMed: 36581470 |
THY1 (CD90) Maintains the Adherens Junctions in Nasopharyngeal Carcinoma via Inhibition of SRC Activation [ Cancers (Basel), 2023, 15(7)2189] | PubMed: 37046850 |
Intracellular CYTL1, a novel tumor suppressor, stabilizes NDUFV1 to inhibit metabolic reprogramming in breast cancer [ Signal Transduct Target Ther, 2022, 7(1):35] | PubMed: 35115484 |
Systematic identification of biomarker-driven drug combinations to overcome resistance [ Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7] | PubMed: 35332332 |
Procr functions as a signaling receptor and is essential for the maintenance and self-renewal of mammary stem cells [ Cell Rep, 2022, 38(12):110548] | PubMed: 35320720 |
Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening [ Cancers (Basel), 2022, 14(6)1575] | PubMed: 35326726 |
Exendin-4, a glucagon-like peptide receptor agonist, facilitates osteoblast differentiation via connexin43 [ Endocrine, 2021, 10.1007/s12020-021-02664-7] | PubMed: 33641073 |
Development of a miRNA-controlled dual-sensing system and its application for targeting miR-21 signaling in tumorigenesis [ Exp Mol Med, 2020, 10.1038/s12276-020-00537-z] | PubMed: 33311703 |
Inhibition of Sema4D/PlexinB1 Signaling Alleviates Vascular Dysfunction in Diabetic Retinopathy [ EMBO Mol Med, 2020, 7;12(2):e10154] | PubMed: 31943789 |
SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1 [ Onco Targets Ther, 2020, 13:4635-4647] | PubMed: 32547094 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。